GlaxoSmithKline PLC (LON: GSK) yog ib lub tuam txhab muaj txiaj ntsig zoo. Hais tias, cov tub ua lag luam tsis tuaj yeem yuav-hauv txhua tus nqi.
Cov tub lag luam yuav tsum kawm paub nyeem cov kev ua lag luam ua rau GSK. Qhov kev tshuaj ntsuam no qhia qee qhov ntsuas tseem ceeb uas qhia koj thaum twg yuav yuav thiab muag thaum twg.
Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam?
Sau npe rau Invezz cov ntawv xov xwm, hnub no.
GSK qhov nruab nrab qhov nruab nrab qhia tau hais tias tus qauv kev voj voog uas yog los ntawm kev ncua sij hawm ncua sij hawm thiab lub neej luv luv. Qhov cuam tshuam yog tias GSK tswj hwm qhov kev sib tw tag nrho.
Rau cov tub ua lag luam, yog li ntawd, txoj hauv kev los yeej yog kev kawm thaum lub zog loj hlob tuaj thiab thaum lub bears pib.
GSK tau teeb tsa rau lub zog nce siab ntawm $ 40.51
RSI tau ua qhov taw qhia zoo tshaj plaws rau cov ntsiab lus ua haujlwm ntawm GSK. Thaum qhov kev nce siab nyob rau qhov kawg, RSI poob qis txawm tias ua ntej qhov nruab nrab txav thiab MACD xaiv qhov sib txawv.
Qhov no tsis tu ncua tshwm sim thaum RSI nyob ze rau 70. Lub RSI poob mus txog rau thaum nws hits 40, thaum lub sij hawm nws tig rov qab sharply, signaling pib ntawm ib tug tshiab bullish trend.
Qhov kev sib tw bullish ces kav ntev li 1.5x lub sij hawm dhau los ntawm tus dais qauv. Yuav luag ib txwm, lub zog pib ntawm theem kev txhawb nqa tseem ceeb.
GlaxoSmithKline tam sim no nyob rau theem kev txhawb nqa tseem ceeb ntawm $ 40.50. Lub lim tiam dhau los, MACD histogram ntawm -0.51 taw qhia qhov pib ntawm kev poob qis ntawm kev sib koom ua ke. Ob qho tib si MACD kab thiab kab teeb liab tseem muaj zog.
Lub lim tiam no tus qauv candlestick qhia txog kev nce siab. Kev sib xyaw ua ke ntawm cov ntsuas no qhia tau tseeb tias GSK yog thaum pib ntawm lwm tus qauv, nrog cov khoom lag luam nce siab tshaj $ 50.
Ntsiab lus
GlaxoSmithKline muaj lub hauv paus muaj zog txhawb nqa tag nrho tus nqi txaus siab. Ntawm tus nqi tam sim no ntawm $ 40.83, GSK yog kev lag luam ntawm qib kev txhawb nqa tseem ceeb. Cov khoom lag luam tau teeb tsa rau qhov kev nce siab ntxiv mus rau ob peb lub lis piam.
Qhov twg yuav tam sim no
Txhawm rau nqis peev yooj yim thiab yooj yim, cov neeg siv xav tau tus nqi qis-nqi nrog nrog cov ntawv sau ntawm kev ntseeg tau. Cov brokers hauv qab no yog cov ntaus nqi siab heev, tau lees paub thoob ntiaj teb, thiab muaj kev nyab xeeb los siv:
- Etoro, ntseeg los ntawm ntau dua 13m cov neeg siv thoob ntiaj teb. Tso npe ntawm no>
- ntsisFlyer, yooj yim, yooj yim siv thiab tswj. Tso npe ntawm no>
Tau qhov twg los: https://invezz.com/news/2022/03/11/glaxosmithkline-is-an-attractive-stock-how-do-you-know-when-to-buy/